Classification and treatment effect evaluation and genetic analysis of hyperphenylalaninemia in Shandong

ZOU Hui,HAN Bing-juan,PU Xiao-ping,TIAN Li-ping

Chinese Journal of Child Health Care ›› 2012, Vol. 20 ›› Issue (3) : 208-210.

PDF(435 KB)
PDF(435 KB)
Chinese Journal of Child Health Care ›› 2012, Vol. 20 ›› Issue (3) : 208-210.

Classification and treatment effect evaluation and genetic analysis of hyperphenylalaninemia in Shandong

  • ZOU Hui,HAN Bing-juan,PU Xiao-ping,TIAN Li-ping
Author information +
History +

Abstract

【Object】 To discuss the classification and treatment effect evaluation and genetic analysis of hyperphenylalaninemia(HPA) in Shandong. 【Mthods】 396 cases of HPA diagnosed by newborn screening in Jinan Classified according to BH4 loading test and urine pterin analysis.Different treatments were given and mornitor the concentration of Phe.The treatment effect was evaluated by the body development and mental development. 【Result】 Among 396 cases of HPA, 356 of them were PAHD,40 cases of BH4D,128 cases of BH4 responsed PAHD.There was no statistically significant difference between the different types of HPA patients and normal children by the body development,including weight and height.132 cases of HPA patients had normal mental development among 155 HPA.IQ of classical PKU( PAHD) showed negative correlation with the concentration of phe.IQ of BH4D patients corresponded with the diagnosed time.There were 6 gene mutation among 11 BH4D patients.42.1% of them were 259C>T. 【Conclusions】 The different clinic and biochemical HPA patients have no statistically significant difference for the body development after treatment while they have statistically significant difference for the intelligence development.The intelligence development level for Classical PKU corresponded with the concentration of Phe while that for BH4D corresponded with the diagnosed time.259C>T is the most common mutation of BH4D.

Key words

hyperphenylalaninemia / phenylalanine hydroxylase deficiency / etrahydrobiopterin deficiency

Cite this article

Download Citations
ZOU Hui,HAN Bing-juan,PU Xiao-ping,TIAN Li-ping. Classification and treatment effect evaluation and genetic analysis of hyperphenylalaninemia in Shandong[J]. Chinese Journal of Child Health Care. 2012, 20(3): 208-210

References

[1] 杨凌,张知新.四氢生物蝶呤反应性苯丙酮尿症的研究进展[J].国外医学·儿科学分册,2005,32(5):305-308.
[2] 顾学范.新生儿代谢性疾病筛查[M].北京:人民卫生出版社,2004:99.
[3] 卫生部.新生儿疾病筛查技术规范(2010版)[R].2010.
[4] Matalon R,Michals-Matalon K,Bhatia G,et al.Large neutral amino acids in the treatment of phenylketonuria(PKU)[J].J Inherit Metab Dis,2008,29(6):732-738
[5] Weglage J,Wiedermann D,Denecke J,et al.Individual blood-brain barrier Phenylalanine transport determines clinical outcome in Phenylketonuria[J].Ann Neurol,2010,50(4):463-467.
[6] 喻唯民,徐力,李晓雯,等.苯丙酮尿症研究18年[J].中国医学科学院学报,2003,25(3):218-222.
[7] MacDonald A,Asplin D.Phenylketonuria: practical dietary management[J].J Fam Health Care,2007,16(3):83-85.
[8] Perez-Dnenas B,Pujol J,Soriano-Mas C,et al.Global and regional volume changes in the brains of patients with phenylketonuria[J].Neurology,2006,66(7):1074-1078.
[9] MacDonald A,Chakrapani A,Hendriksz C,et al.Protein substitute dosage in PKU:how much do young patients need?[J].Arch Dis Child,2006,91(7):588-593.
[10] Moller HE,Vermathen P,Ullrich K,et al.In-vivo NMR spectroscopy in patients with Phenylketonuria:changes of cerebral Phenylalanine levels under dietary treatment[J].Neuropediatrics,1995,26(4):199-202.
[11] Hvas AM,Nexo E,Nielsen JB.Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU)[J].J Inherit Metab Dis,2006,29(1):47-53.
[12] 顾学范.新生儿代谢性疾病筛查[M].北京:人民卫生出版社,2004:99.
[13] 叶军,刘晓琴,马燮琴,等.Screening for tetrahydrobiopterin deficiency among phenylketonuria patients in Southern China[J].Chinese Medical Journal,2002,115(2):217-221.
PDF(435 KB)

Accesses

Citation

Detail

Sections
Recommended

/